A review of the interest of sugammadex for deep neuromuscular blockade management in Belgium

Acta Anaesthesiologica Belgica

Volumn 64, Issue 2, 2013, Pages 49-60

  Dubois, Philippe E ^a   Mulier, J P ^b  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^b Dep of Anesthesiology   (Belgium)

Author keywords

Neostigmine; Neuromuscular block; Neuromuscular transmission monitoring; Residual neuromuscular block; Rocuronium; Sugammadex

Indexed keywords

ACETYLCHOLINE; AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIVITAMIN K; ATRACURIUM BESILATE; ATROPINE; CISATRACURIUM; DABIGATRAN; GLYCOPYRRONIUM BROMIDE; HEPARIN; HEPARINOID; MAGNESIUM SULFATE; MIVACURIUM; NEOSTIGMINE; NEUROMUSCULAR BLOCKING AGENT; RIVAROXABAN; ROCURONIUM; SUGAMMADEX; SUXAMETHONIUM; VECURONIUM;

ALGORITHM; ALLERGIC REACTION; ANESTHESIA; ANESTHESIST; BELGIUM; BLEEDING; BRADYCARDIA; CLINICAL PRACTICE; COST; COUGHING; EXTUBATION; HOSPITALIZATION; HUMAN; INTENSIVE CARE UNIT; INTUBATION; LAPAROTOMY; LUNG DISEASE; MEDICAL RECORD; MONITORING; MUSCLE RELAXATION; NEUROMUSCULAR BLOCKING; NEUROMUSCULAR FUNCTION; NEUROMUSCULAR TRANSMISSION; PATIENT SAFETY; POSTANESTHESIA CARE; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PAIN; PROSTATECTOMY; REIMBURSEMENT; REVIEW; RISK; SIDE EFFECT; TASTE;

ALGORITHMS; BELGIUM; GAMMA-CYCLODEXTRINS; HUMANS; MUSCLE RELAXATION; NEOSTIGMINE; NEUROMUSCULAR BLOCKADE; NEUROMUSCULAR MONITORING;

EID: 84886783563     PISSN: 00015164     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (82)

1. d'Hollander A. A., Duvaldestin P., Henzel D., Delcroix C., Desmonts J. M., Relationship between decay of plasma concentration of fazadinium and recovery from its neuromuscular blocking effect, BR. J. ANAESTH., 53, 853-8, 1981. (Pubitemid 11044347)
2. Claudius C., Viby-Mogensen J., Acceleromyography for use in scientific and clinical practice. A systematic review of the evidence, ANESTHESIOLOGY, 108, 1117-40, 2008.
3. Viby-Mogensen J., Howardy-Hansen P., Chraemmer-Jørgensen B., Ording H., Engbaek J., Nielsen A., Posttetanic count (PTC): a new method of evaluating an intense nondepolarizing neuromuscular blockade, ANESTHESIOLOGY, 55, 458-61, 1981. (Pubitemid 12199194)
4. Fuchs-Buder T., Claudius C., Skovgaard L. T., Eriksson L. I., Mirakhur R. K., Viby-Mogensen J., Good clinical research practice in pharmacodynamic studies of neuromuscular blocking agents II: the Stockholm revision. ACTA ANAESTHESIOL. SCAND., 51, 789-808, 2007. (Pubitemid 47063004)
5. Fuchs-Buder T., Schreiber J.-U., Meistelman C., Monitoring neuromuscular block: an update, ANAESTHESIA 64, 82-89, 2009.
6. Puhringer F. K., Heier T., Dodgson M., Erkola O., Goonetilleke P., Hofmockel R., Gaetke M. R., Mortensen C. R., Upadhyaya B., Eriksson L. I., Double-blind comparison of the variability in spontaneous recovery of cisatracurium- and vecuronium-induced neuromuscular block in adult and elderly patients, ACTA ANAESTHESIOL. SCAND., 46, 364-71, 2002. (Pubitemid 34454429)
7. Cammu G., Interactions of neuromuscular blocking drugs, ACTA ANAESTH. BELG., 52, 357-363, 2001. (Pubitemid 34028404)
8. Puura A. I., Rorarius M. G., Manninen P., Hopput S., Baer G. A., The costs of intense neuromuscular block for anesthesia during endolaryngeal procedures due to waiting time, ANESTH. ANALG., 88, 1335-9, 1999. (Pubitemid 29246949)
9. Murphy G. S., Brull S. J., Residual neuromuscular block: lessons unlearned. Part I: definitions, incidence, and adverse physiologic effects of residual neuromuscular block, ANESTH. ANALG., 111, 120-8, 2010.
10. Plaud B., Debaene B., Donati F., Marty J., Residual paralysis after emergence from anaesthesia, ANESTHESIOLOGY, 112, 1013-22, 2010.
11. Eikermann M., Vogt F. M., Herbstreit F., Vahid-Dastgerdi M., Zenge M. O., Ochterbeck C., de Graff A. Peters J., The predisposition to inspiratory upper airway collapse during partial neuromuscular block, AM. J. RESPIR. CRIT. MED., 175, 9-15, 2007. (Pubitemid 46105303)
12. Murphy G. S., Brull S. J., Residual neuromuscular block: lessons unlearned. Part II: methods to reduce the risk of residual weakness, ANESTH. ANALG., 111, 129-40, 2010.
13. Viby-Mogensen J., Claudius C., Evidence-based management of neuromuscular Block, ANESTH. ANALG., 111, 1-2, 2010.
14. Miller R. D., Ward T. A, Monitoring and pharmacologic reversal of a nondepolarizing neuromuscular blockade should be routine, ANESTH. ANALG., 111, 3-5, 2010.
15. Sauer M., Stahn A., Soltesz S., Noeldge-Schomburg G., Mencke T., The influence of residual neuromuscular block on the incidence of critical respiratory events. A randomised, prospective, placebo-controlled trial, EUR. J. ANAESTHESIOL., 28, 842-8, 2011.
16. Murphy G. S., Szokol J. W., Avram M. J., Greenberg S. B., Marymont J. H., Vender J. S., Gray J., Landry E., Gupta D. K., Intraoperative acceleromyography monitoring reduces symptoms of muscle weakness and improves quality of recovery in the early postoperative period. ANESTHESIOLOGY, 115, 946-54, 2011.
17. Cammu G., De Witte J., De Veylder J., Byttebier G., Vandeput D., Foubert L., Vandenbroucke G., Deloof T., Postoperative residual paralysis in outpatients versus inpatients, ANESTH. ANALG., 102, 426-9, 2006. (Pubitemid 43152590)
18. Murphy G. S., Szokol J. W., Marymont J. H., Franklin M., Avram M. J., Vender J. S., Residual paralysis at the time of tracheal extubation, ANESTH. ANALG., 100, 1840-5, 2005. (Pubitemid 40712750)
19. Murphy G. S., Szokol J. W., Marymont J. H., Greenberg S. B., Avram M. J., Vender J. S., Nisman M., Intraoperative acceleromyographic monitoring reduces the risk of residual neuromuscular blockade and adverse respiratory events in the postanesthesia care unit, ANESTHESIOLOGY, 109, 389-99, 2008.
20. Meistelman C., Plaud B., Donati F., Rocuronium neuromuscular blockade at the adductor muscles of the larynx and adductor pollicis in humans, CAN J ANAESTH 39, 665-9, 1992.
21. Fernando P. U., Viby-Mogensen J., Bonsu A. K., Tamilarasan A., Muchhal K. K., Lambourne A., Relationship between posttetanic count and response to carinal stimulation during vecuronium-induced neuromuscular blockade. ACTA ANAESTHESIOL. SCAND., 31, 593-6, 1987. (Pubitemid 18047379)
22. Viby-Mogensen J., Neuromuscular monitoring, CURRENT OPINION IN ANESTHESIOLOGY, 14, 655-9, 2001. (Pubitemid 33135717)
23. Hemmerling T. M., Donati F., Neuromuscular blockade at the larynx, the diaphragm and the corrugator supercilii muscle: a review, CAN. J. ANESTH., 50, 779-94, 2003. (Pubitemid 37455531)
24. Dhonneur G., Kirov K., Motamed C., Amathieu R., Kamoun W., Slavov V., Ndoko S. K., Post-tetanic count at adductor pollicis is a better indicator of early diaphragmatic recovery than train-of-four count at corrugator supercilii, BR. J. ANAESTH., 99, 376-9, 2007. (Pubitemid 47351040)
25. Dubois P. E., Gourdin M., Russell K., Jamart J., Installation of the hand influences acceleromyography measurement. A comparison with mechanomyography during neuromuscular block recovery, ACTA ANAESTH. BELG., 56, 163-6, 2005. (Pubitemid 40943864)
26. Miller R. D., Antagonism of neuromuscular blockade, ANESTHESIOLOGY, 44, 293, 1976.
27. Srivastava A., Hunter J. M., Reversal of neuromuscular block, BR. J. ANAESTH., 103, 115-29, 2009.
28. Arbous M. S., Meursing A. E., van Kleef J. W., de Lange J. J., Spoormans H. H., Touw P., Werner F. M., Grobbee D. E., Impact of anesthesia management characteristics on severe morbidity and mortality. ANESTHESIOLOGY, 102, 257-68, 2005. (Pubitemid 40189072)
29. Bartkowsky R. R., Incomplete reversal of pancuronium neuromuscular blockade by neostigmine, pyridostigmine and edrophonium, ANESTH. ANALG., 66, 594-598, 1987.
30. Kirkegaard H., Heier T., Caldwell J. E., Efficacy of tactile-guided reversal from cisatracurium-induced neuromuscular block, ANESTHESIOLOGY, 96, 45-50, 2002. (Pubitemid 34032480)
31. Eikermann M., Fassbender P., Malhotra A., Takahashi M., Kubo S., Jordan A. S., Gautam S., White D. P., Chamberlin N. L., Unwarranted administration of acetylcholinesterase inhibitors can impair genioglossus and diaphragm muscle function, ANESTHESIOLOGY, 107, 621-9, 2007. (Pubitemid 47480569)
32. Kopman A. F., Eikermann M., Antagonism of non-depolarising neuromuscular block: current practice, ANAESTHESIA, 64, 22-30, 2009.
33. Blobner M., Eriksson L. I., Scholz J., Motsch J., Della Rocca G., Prins M. E., Reversal of rocuronium-induced neuromuscular blockade with sugammadex compared with neostigmine during sevoflurane anaesthesia: results of a randomised, controlled trial, EUR. J. ANAESTHESIOL., 27, 874-881, 2010.
34. Fuchs-Buder T., Ziegenfuss T., Lysakowski K., Tassonyi E., Antagonism of vecuronium-induced neuromuscular block in patients pretreated with magnesium sulphate: dose-effect relationship of neostigmine, BR. J. ANAESTH., 82, 61-5, 1999. (Pubitemid 29043130)
35. Reid J. E., Breslin D. S., Mirakhur R. K., Hayes A. H., Neostigmine antagonism of rocuronium block during anesthesia with sevoflurane, isoflurane or propofol. CAN. J. ANAESTH., 48, 351-5, 2002.
36. Suzuki T., Masaki G., Ogawa S., Neostigmine-induced reversal of vecuronium in normal weight, overweight and obese female patients, BR. J. ANAESTH., 97, 160-3, 2006. (Pubitemid 44295699)
37. Kopman A. F., Kopman D. J., Ng J., Zank L. M., Antagonism of profound cisatracurium and rocuronium block: the role of objective assessment of neuromuscular function, J. CLIN. ANAESTH., 17, 30-5, 2005. (Pubitemid 40255212)
38. Baurain M. J., Dernovoi B. S., d'Hollander A. A., Hennart D. A., Cantraine F. R., Conditions to optimize the reversal action of neostigmine upon a vecuronium-induced neuromuscular block. ACTA ANAESTHESIOL. SCAND., 40, 574-8, 1996. (Pubitemid 26183047)
39. McCourt K. C., Mirakhur R. K., Kerr C. M., Dosage of neostigmine for reversal of rocuronium block from two levels of spontaneous recovery, Anaesthesia, 54, 651-5, 1999. (Pubitemid 29353859)
40. Fuchs-Buder T., Meistelman C., Alla F., Grandjean A., Wuthrich Y., Donati F., Antagonism of low degree of atracurium-induced neuromuscular blockade: dose-effect relationship for neostigmine. ANESTHESIOLOGY, 112, 34-40, 2010.
41. Savarese J. J., Miller R. D., Lien C. A., Caldwell J. E., Pharmacology of muscle relaxants and their antagonists, ANESTHESIA, 4th edn., p 417-488. New York, Churchill Livingstone, 1994.
42. Booij L. H., van Egmond J., Driessen J. J., de Boer H. D., In vivo animal studies with sugammadex, ANAESTHESIA, 64, 38-44, 2009.
43. Gijsenbergh F., Ramael S., Houwing N., van Iersel T., First human exposure of Org 25969, a novel agent to reverse the action of rocuronium bromide, ANESTHESIOLOGY, 103, 695-703, 2005. (Pubitemid 41415517)
44. Booij L. H., Cyclodextrins and the emergence of sugammadex, ANAESTHESIA, 64, 31-37, 2009.
45. Mirakhur R. K., Sugammadex in clinical practice, ANAESTHESIA, 64, 45-54, 2009.
46. Van Lancker P., Dillemans B., Bogaert T., Mulier J. P., De Kock M., Haspeslagh M., Ideal versus corrected body weight for dosage of sugammadex in morbidly obese patients, ANAESTHESIA, 66, 721-5, 2011.
47. Vanacker B. F., Vermeyen K. M., Struys M. M., Rietbergen H., Vandermeersch E., Saldien V., Kalmar A. F., Prins M. E., Reversal of rocuronium induced neuromuscular block with the novel drug sugammadex is equally effective under maintenance anaesthestesia with propofol or sevoflurane, ANESTH. ANALG., 104, 563-8, 2007.
48. Godai K., Hasegawa-Moriyama M., Kuniyoshi T., Kakoi T., Ikoma K., Isowaki S., Matsunaga A., Kanmura Y., Three cases of suspected sugammadex-induced hypersensitivity reactions. BR. J. ANAESTH., 109, 216-8, 2012.
49. Capron F., Alla F., Meistelman C., Fuchs-Buder T., Can acceleromyography detect low levels of residual paralysis? A probability approach to detect a mechanomyographic train-of-four ratio of 0.9, ANESTHESIOLOGY, 100, 1119-24, 2004. (Pubitemid 38541966)
50. Baurain M. J., Hennart D. A., Godschalx A., Huybrechts I., Nasrallah G., d'Hollander A. A., Cantraine F., Visual evaluation of residual curarization in anesthetized patients using one hundred-hertz, five-second tetanic stimulation at the adductor pollicis muscle, ANESTH. ANALG., 87, 185-9, 1998. (Pubitemid 28311636)
51. Samet A., Capron F., Alla F., Meistelman C., Fuchs-Buder T., Single AMG train-of-four, 100-Hertz tetanus or Double-Burst Stimulation: Which test performs better to detect residual paralysis?, ANESTHESIOLOGY, 102, 51-6, 2005. (Pubitemid 40082839)
52. Paton W. D., Waud D. R, The margin of safety of neuromuscular transmission, J. PHYSIOL., 191, 59-90, 1967.
53. Waud B. E., Waud D. R., The relation between the response to "train-of-four" stimulation and receptor occlusion during competitive neuromuscular block, ANESTHESIOLOGY, 37, 413-6, 1972.
54. Hans G. A., Bosenge B., Bonhomme V. L., Brichant J. F., Venneman I. M., Hans P. C., Intravenous magnesium reestablishes neuromuscular block after spontaneous recovery from an intubating dose of rocuronium: a randomised controlled trial, EUR. J. ANAESTHESIOL., 29, 95-9, 2012.
55. Curtis R., Lomax S., Patel B., Use of sugammadex in a 'can't intubate, can't ventilate' situation. BR. J. ANAESTH., 108, 612-4, 2012.
56. Mencke T., Echternach M., Kleinschmidt S., Lux P., Barth V., Plinkert P. K., Fuchs-Buder T., Laryngeal morbidity and quality of tracheal intubation: a randomized controlled trial. ANESTHESIOLOGY, 98, 1049-56, 2003. (Pubitemid 36520190)
57. Stevens J. B., Vescovo M. V., Harris K. C., Walker S. C., Hickey R., Tracheal intubation using alfentanil and no muscle relaxant: is the choice of hypnotic important?, ANESTH. ANALG., 84, 1222-6, 1997. (Pubitemid 27250461)
58. Green R. S., Edwards J., Sabri E., Fergusson D., Evaluation of the incidence, risk factors, and impact on patient outcomes of postintubation hemodynamic instability, CJEM, 14, 74-82, 2012.
59. Dunn M. J., Mitchell R., Souza C. D., Drummond G., Evaluation of propofol and remifentanil for intravenous sedation for reducing shoulder dislocations in the emergency department, EMERG. MED. J., 23, 57-8, 2006. (Pubitemid 43056366)
60. Fitch R. W., Kuhn J. E., Intraarticular lidocaine versus intravenous procedural sedation with narcotics and benzodiazepines for reduction of the dislocated shoulder: a systematic review, ACAD. EMERG. MED., 15, 703-8, 2008.
61. Chassard D., Berrada K., Tournadre J., Boulétreau P., The effects of neuromuscular block on peak airway pressure and abdominal elastance during pneumoperitoneum, ANESTH. ANALG., 82, 525-7, 1996. (Pubitemid 26072955)
62. King M., Sujirattanawimol N., Danielson D. R., Hall B. A., Schroeder D. R., Warner D. O., Requirements for muscle relaxants during radical retropubic prostatectomy, ANESTHESIOLOGY, 93, 1392-7, 2000.
63. Neudecker J., Sauerland S., Neugebauer E., Bergamaschi R., Bonjer H. J., Cuschieri A., Fuchs K. H., Jacobi Ch., Jansen F. W., Koivusalo A. M., Lacy A., McMahon M. J., Millat B., Schwenk W., The European association for endoscopic surgery clinical practice guideline on the pneumoperitoneum for laparoscopic surgery, SURG. ENDOSC., 16, 1121-43, 2002. (Pubitemid 34747515)
64. Joshipura V. P., Haribhakti S. P., Patel N. R., Naik R. P., Soni H. N., Patel B., Bhavsar M. S., Narwaria M. B., Thakker R., A prospective randomized controlled study comparing low pressure versus high-pressure pneumoperitoneum during laparoscopic cholecystectomy, SURG. LAPAROSC. ENDOSC. PERCUTAN. TECH., 19, 234-40, 2009.
65. Wallace D. H., Serpell M. G., Baxter J. N., O'Dwyer P. J., Randomized trial of different insufflation pressure for laparoscopic cholecystectomy, BR. J. SURG., 84, 455-8, 1997. (Pubitemid 27196280)
66. Mulier J. P., Dillemans B., Sablon T., Danneels I., Effects of muscle relaxants on the abdominal pressure volume relation, EUR. J. ANAESTH., 23, S42, 2006.
67. Lindholm M. L., Träff S., Granath F., Greenwald S. D., Ekbom A., Lennmarken C., Sandin R. H., Mortality within 2 years after surgery in relation to low intraoperative bispectral index values and preexisting malignant disease. ANESTH. ANALG., 108, 508-12, 2009.
68. Amao R., Zornow M. H., Cowan R. M., Cheng D. C., Morte J. B., Allard M. W., Use of sugammadex in patients with a history of pulmonary disease, J. CLIN. ANESTH., 24, 289-97, 2012.
69. Caldwell J. E., Reversal of residual neuromuscular block with neostigmine at one to four hours after a single intubating dose of vecuronium. ANESTH. ANALG., 80, 1168-74, 1995.
70. Lock G., Loureiro Fialho G., Castro Lima D., Simoes Almeida M. C., Electrocardiographic changes after neostigmine-atropine mixture. J ANESTH. CLINIC RES., 3, 188, 2012.
71. Hemmerling T. M., Zaouter C., Geldner G., Nauheimer D., Sugammadex - a short review and clinical recommendations for the cardiac anesthesiologist. ANN. CARD. ANAESTH., 13, 206-16, 2010.
72. Dahl V., Pendeville P. E., Hollmann M. W., Heier T., Abels E. A., Blobner M., Safety and efficacy of sugammadex for the reversal of rocuronium-induced neuromuscular blockade in cardiac patients undergoing noncardiac surgery, EUR. J. ANAESTHESIOL., 26, 874-84, 2009.
73. Staals L. M., Snoeck M. M., Driessen J. J., Flockton E. A., Heeringa M., Hunter J. M., Multicentre, parallel-group, comparative trial evaluating the efficacy and safety of sugammadex in patients with end-stage renal failure or normal renal function, BR. J. ANAESTH., 101, 492-7, 2008.
74. Baumgartner P., Rocuronium and sugammadex in myotonic dystrophy. ANAESTH. INTENSIVE CARE, 38, 959-60, 2010.
75. de Boer H. D., van Esmond J., Booij L. H., Driessen J. J., Reversal of rocuronium-induced profound neuromuscular block by sugammadex in Duchenne muscular dystrophy. PAEDIATR. ANAESTH., 19, 1226-8, 2009.
76. de Boer H. D., van Egmond J., Driessen J. J., Booij L. H., A new approach to anesthesia management in myasthenia gravis: reversal of neuromuscular blockade by sugammadex, REV. ESP. ANESTESIOL. REANIM., 57, 181-4, 2010.
77. Suzuki T., Kitajima O., Ueda K., Kondo Y., Kato J., Ogawa S., Reversibility of rocuronium-induced profound neuromuscular block with sugammadex in younger and older patients, BR. J. ANAESTH., 106, 823-6, 2011.
78. Veiga Ruiz G., Carceles Baron M. D., Dominguez Serrano N., Lopez Fuentes L., Orozco Montes J., Alvarez-Gomez J. A., Sugammadex reversal efficacy and security vs neostigmine in the rocuronium - induced neuromuscular blockade in paediatric patients, EUR. J. ANAESTHESIOL., 28, Supp 48, 2011
79. Gaszynski T., Szewczyk T., Gaszynski W., Randomized comparison of sugammadex and neostigmine for reversal of rocuronium-induced muscle relaxation in morbidly obese undergoing general anaesthesia, BR. J. ANAESTH., 108, 236-9, 2012.
80. Tramer M. R., Fuchs-Buder T., Omitting antagonism of neuromuscular block: effect on postoperative nausea and vomiting and risk of residual paralysis. A systematic review. BR. J. ANAESTH., 82, 379-86, 1999. (Pubitemid 29112540)
81. Cheng C. R., Sessler D. I., Apfel C. C., Does neostigmine administration produce a clinically important increase in postoperative nausea and vomiting?, ANESTH. ANALG., 101, 1349-55, 2005. (Pubitemid 41531870)
82. Naguib M., Kopman A. F., Lien C. A., Hunter J. M., Lopez A., Brull S. J., A survey of current management of neuromuscular block in the United States and Europe, ANESTH. ANALG., 111, 110-9, 2010.